152 related articles for article (PubMed ID: 38718391)
1. The relationship between splenic dose and radiation-induced lymphopenia.
Ma Y; Kong Y; Zhang S; Peng Y; Xu M; Zhang J; Xu H; Hong Z; Xing P; Qian J; Zhang L
J Radiat Res; 2024 May; 65(3):337-349. PubMed ID: 38718391
[TBL] [Abstract][Full Text] [Related]
2. Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?
Chadha AS; Liu G; Chen HC; Das P; Minsky BD; Mahmood U; Delclos ME; Suh Y; Sawakuchi GO; Beddar S; Katz MH; Fleming JB; Javle MM; Varadhachary GR; Wolff RA; Crane CH; Wang X; Thames H; Krishnan S
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):323-332. PubMed ID: 28068240
[TBL] [Abstract][Full Text] [Related]
3. Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma.
Liu J; Zhao Q; Deng W; Lu J; Xu X; Wang R; Li X; Yue J
Radiat Oncol; 2017 May; 12(1):90. PubMed ID: 28558844
[TBL] [Abstract][Full Text] [Related]
4. Vertebral body and splenic irradiation are associated with lymphopenia in localized pancreatic cancer treated with stereotactic body radiation therapy.
Reddy AV; Deek MP; Jackson JF; Hill CS; Sehgal S; He J; Zheng L; Herman JM; Meyer J; Narang AK
Radiat Oncol; 2021 Dec; 16(1):242. PubMed ID: 34952610
[TBL] [Abstract][Full Text] [Related]
5. Splenic irradiation contributes to grade ≥ 3 lymphopenia after adjuvant chemoradiation for stomach cancer.
Lee SF; Yip PL; Wong A; Ng F; Koh V; Wong LC; Luk H; Ng CK; Lee FAS; Mamon HJ
Clin Transl Radiat Oncol; 2022 Sep; 36():83-90. PubMed ID: 35909437
[TBL] [Abstract][Full Text] [Related]
6. Post-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapy.
Joseph N; McWilliam A; Kennedy J; Haslett K; Mahil J; Gavarraju A; Mistry H; Van Herk M; Faivre-Finn C; Choudhury A
Radiother Oncol; 2019 Jun; 135():115-119. PubMed ID: 31015156
[TBL] [Abstract][Full Text] [Related]
7. Spleen Dose-Volume Parameters as a Predictor of Treatment-related Lymphopenia During Definitive Chemoradiotherapy for Esophageal Cancer.
Saito T; Toya R; Yoshida N; Shono T; Matsuyama T; Ninomura S; Watakabe T; Sasaki Y; Baba H; Oya N
In Vivo; 2018; 32(6):1519-1525. PubMed ID: 30348711
[TBL] [Abstract][Full Text] [Related]
8. Predictive significance of surgery-induced lymphopenia on the survival after curative resection for locally advanced gastric cancer: a retrospective cohort analysis.
Aizawa M; Yabusaki H; Matsuki A; Bamba T; Nakagawa S
World J Surg Oncol; 2023 Jan; 21(1):7. PubMed ID: 36647123
[TBL] [Abstract][Full Text] [Related]
9. Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer.
Cho O; Oh YT; Chun M; Noh OK; Lee HW
Tumour Biol; 2016 Jan; 37(1):971-8. PubMed ID: 26264618
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy.
Davuluri R; Jiang W; Fang P; Xu C; Komaki R; Gomez DR; Welsh J; Cox JD; Crane CH; Hsu CC; Lin SH
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):128-135. PubMed ID: 28816138
[TBL] [Abstract][Full Text] [Related]
11. Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: impact of treatment modality and the baseline lymphocyte count.
Xie X; Gong S; Jin H; Yang P; Xu T; Cai Y; Guo C; Zhang R; Lou F; Yang W; Wang H
Radiat Oncol; 2020 Mar; 15(1):65. PubMed ID: 32169088
[TBL] [Abstract][Full Text] [Related]
12. The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy.
Deng W; Xu C; Liu A; van Rossum PSN; Deng W; Liao Z; Koong AC; Mohan R; Lin SH
Radiother Oncol; 2019 Apr; 133():9-15. PubMed ID: 30935587
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer.
Patel DA; Xi J; Luo J; Hassan B; Thomas S; Ma CX; Campian JL
Breast Cancer Res Treat; 2019 Apr; 174(2):443-452. PubMed ID: 30604000
[TBL] [Abstract][Full Text] [Related]
14. Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy.
Chen D; Patel RR; Verma V; Ramapriyan R; Barsoumian HB; Cortez MA; Welsh JW
Radiother Oncol; 2020 Sep; 150():114-120. PubMed ID: 32525003
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of the Kinetics of Radiation-Induced Lymphocyte Loss in Patients Treated with External Beam Radiation Therapy.
Ellsworth SG; Yalamanchali A; Zhang H; Grossman SA; Hobbs R; Jin JY
Radiat Res; 2020 Jan; 193(1):73-81. PubMed ID: 31675264
[TBL] [Abstract][Full Text] [Related]
16. Association between unintentional splenic radiation and lymphopenia and high neutrophil/lymphocyte ratio after radiotherapy in patients with esophageal cancer.
Sakaguchi M; Maebayashi T; Aizawa T; Ishibashi N; Okada M
Transl Cancer Res; 2021 Dec; 10(12):5076-5084. PubMed ID: 35116359
[TBL] [Abstract][Full Text] [Related]
17. Risk of on-treatment lymphopenia is associated with treatment outcome and efficacy of consolidation immunotherapy in patients with non-small cell lung cancer treated with concurrent chemoradiotherapy.
Yang G; Yoon HI; Lee J; Kim J; Kim H; Cho J; Lee CG; Chang JS; Cho Y; Kim JS; Kim KH
Radiother Oncol; 2023 Dec; 189():109934. PubMed ID: 37783291
[TBL] [Abstract][Full Text] [Related]
18. Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and Chemoradiotherapy.
Cheng X; Chen B; Wang S; Zhang J; Zhu J; Liu M; Liu S; Xi M
Oncologist; 2023 Aug; 28(8):e606-e616. PubMed ID: 37061835
[TBL] [Abstract][Full Text] [Related]
19. Association of Posttreatment Lymphopenia and Elevated Neutrophil-to-Lymphocyte Ratio With Poor Clinical Outcomes in Patients With Human Papillomavirus-Negative Oropharyngeal Cancers.
Lin AJ; Gang M; Rao YJ; Campian J; Daly M; Gay H; Oppelt P; Jackson RS; Rich J; Paniello R; Zevallos J; Hallahan D; Adkins D; Thorstad W
JAMA Otolaryngol Head Neck Surg; 2019 May; 145(5):413-421. PubMed ID: 30920592
[TBL] [Abstract][Full Text] [Related]
20. Patient-Specific Lymphocyte Loss Kinetics as Biomarker of Spleen Dose in Patients Undergoing Radiation Therapy for Upper Abdominal Malignancies.
Yalamanchali A; Zhang H; Huang KC; Mohan R; Lin SH; Zhu C; Grossman SA; Jin JY; Ellsworth SG
Adv Radiat Oncol; 2021; 6(1):100545. PubMed ID: 33665481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]